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Abstract
Background: Gastric cancer is one of the most common cancers in the world. The ‘‘economically developed countries’’ life
style, including diet, constitutes a risk factor favoring this cancer. Diet modulation may lower digestive cancer incidence.
Among promising food components, dairy propionibacteria were shown to trigger apoptosis of human colon cancer cells,
via the release of short-chain fatty acids acetate and propionate.
Methodology/Principal Findings: A fermented milk, exclusively fermented by P. freudenreichii, was recently designed. In
this work, the pro-apoptotic potential of this new fermented milk was demonstrated on HGT-1 human gastric cancer cells.
Fermented milk supernatant induced typical features of apoptosis including chromatin condensation, formation of
apoptotic bodies, DNA laddering, cell cycle arrest and emergence of a subG1 population, phosphatidylserine exposure at
the plasma membrane outer leaflet, reactive oxygen species accumulation, mitochondrial transmembrane potential
disruption, caspase activation and cytochrome c release. Remarkably, this new fermented milk containing P. freudenreichii
enhanced the cytotoxicity of camptothecin, a drug used in gastric cancer chemotherapy.
Conclusions/Significance: Such new probiotic fermented milk may thus be useful as part of a preventive diet designed to
prevent gastric cancer and/or as a food supplement to potentiate cancer therapeutic treatments.
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Introduction
Diet modulates the risk of developing gastric cancer
Cancer is the main cause of death in economically developed
countries resulting from cancer-associated lifestyle choices includ-
ing smoking, physical inactivity, and ‘‘westernized’’ diet [1].
Indeed, the role of diet in cancer development is strongly
supported by epidemiological studies, in particular regarding
cancers of the digestive tract. Gastric cancer (GC) represents the
third type of lethal cancers for men in the world. In 2008, 640.600
cases of GC were estimated, causing 464.400 deaths worldwide
[1]. This disease is particularly frequent in eastern Asia, and in
central and eastern Europe. The most important etiological factors
involved in gastric carcinogenesis are diet and Helicobacter pylori
infection. Substantial evidence, mainly from case-control studies,
suggests that the risk of contracting GC is increased by high intake
of salted, pickled or smoked traditionally foods, as well as dried fish
and meat. On the contrary, fibers, fresh vegetables and fruit,
perhaps due to their vitamin C content, were found to be inversely
associated with GC risk [2,3]. The impact of natural/food
components on carcinogenesis of the stomach has thus been
investigated during the last few decades [4–6]. Among these,
probiotics and their ability to inhibit the development of cancer
attracted scientific interest [7,8]. A probiotic is generally defined as
‘‘a live microorganism which, when administered in adequate
amounts, confers a health benefit to the host’’ [9]. While some
microorganisms like H. pylori may favor GC, others may have a
beneficial effect by preventing digestive cancers. In particular,
selected strains of probiotic bacteria can limit cancer development
in animal models of carcinogenesis [10]. This was particularly
evidenced for colon cancer whereas less is known on the possible
effects of probiotics on GC. A possible mechanistic explanation of
such a protective effect is the in situ release of anti-carcinogenic
metabolites such as short chain fatty acids (SCFAs).
Short chain fatty acids induce apoptosis of cancer cells
SCFA, including acetate, propionate and butyrate, are impor-
tant anions of the intestinal content and their concentration may
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e31892be modulated by the diet. They were shown to play a key role in
important physiological functions including modulation of the
digestive epithelial cells proliferation/apoptosis balance. This
involves SCFA-mediated cell-cycle arrest, histone deacetylase
inhibition and apoptosis stimulation in transformed cells, but also
stimulation of differentiation in healthy cells [11,12]. It has also
been reported that the SCFAs butyrate and propionate both
induce apoptosis in human gastric carcinoma cell lines [13–15].
Apoptosis is a natural physiologic process allowing cell number
regulation and constitutes a target for anti-cancer chemotherapy
[16]. Apoptosis allows depletion of cancer cells in a ‘‘clean’’
manner. Cancer cells fragment in a coordinated chain reaction
and the residues are absorbed by adjacent tissues and immune
system [17,18]. Two main apoptotic pathways have been
described: the extrinsic pathway, which is mediated by activation
of death receptors and caspase 8, and the intrinsic pathway, in
which mitochondria and caspase 9 are involved [16]. Generally, in
cancer cells, the apoptotic function is lacking, which may explain
their sustained proliferation and consequently the formation of
tumors. The ability to induce apoptosis of cancer cells is thus
recognized for its therapeutic potential [16]. Since dairy
propionibacteria are able to produce beneficial pro-apoptotic
SCFAs, they may prove useful in cancer prevention or treatment.
Propionibacterium freudenreichii can favor apoptotic
depletion of digestive cancer cells
This probiotic dairy propionibacterium was shown to induce
cell death of different human colon cancer cell lines through
apoptosis induction, in co-cultures [19]. The active compounds,
secreted into the medium, trigger the intrinsic mitochondrial
apoptotic pathway in cultured human colorectal cancer cells. In
particular, the SCFAs acetate and propionate released by P.
freudenreichii induce apoptosis by acting on the mitochondrial
adenine nucleotide translocator, causing mitochondria depolar-
ization and permeabilisation, leakage of cytochrome c and caspase
activation [19,20]. However, propionibacterial supernatants are
still more pro-apoptotic than the SCFAs acetate and propionate,
used at the concentrations measured in supernatants, suggesting
that other compounds may be involved in this effect. Selected
strains of P. freudenreichii remain live and metabolically active within
the intestine of humans and of human microbiota-associated rats
where they produce SCFAs [21,22]. Accordingly, they were shown
to increase apoptosis in transformed colon epithelial cells of such
rats fed with the carcinogen 1,2-dimethylhydrazine (DMH), but
not in control healthy ones [23]. Propionibacteria could constitute
probiotics favoring colon cancer prophylaxis, provided they reach
their target alive and metabolically active. In this context, the
vector, or probiotic delivery vehicle, was shown to determine
propionibacteria survival and activity [21,24,25]. Complex dairy
products such as yogurt and cheese, in particular, protect
propionibacteria from stress, but contain a complex mixture of
bacteria. It is thus not possible to attribute the beneficial effect to a
particular strain.
A fermented milk was evaluated as propionibacteria
delivery vehicle in this context
In this study, we used a new food-grade fermented milk
containing only P. freudenreichii as a sole microflora. As this product
contains both live propionibacteria and their active metabolites, it
should bring them in contact with the gastric mucosa when
ingested. This fermented milk was investigated with respect to
HGT-1 human gastric cancer cells apoptosis induction. Indeed,
propionibacteria are known to kill human colon cancer cells but
their effect on gastric cancer cells is unknown. The fermented milk
killed HGT-1 cells in a time- and dose-dependent manner. Typical
features of the apoptosis process were observed, including viability
drop, chromatin condensation, apoptotic bodies’ formation, DNA
laddering, ROS production, mitochondrial membrane potential
perturbation, caspase activation, cell cycle arrest and emergence of
a subG1 population.
Results
P. freudenreichii fermented milk kills human gastric and
colon cancer cells
P. freudenreichii ITG P9 grew in 72 h at 30uC in supplemented
milk and supplemented milk ultrafiltrate to reach final population
of 9,43 log10 colony-forming units (cfu)/mL and 9.35 log10 cfu/
mL, respectively. The SCFA concentrations were 26.21 mM
acetate and 54.47 mM propionate (2.08 propionate/acetate ratio)
in the milk fermented supernatant whereas they were 24.00 mM
and 53.32 mM (2.22 ratio) in the fermented milk ultrafiltrate
supernatant. These ratios were expected for propionibacteria,
which generally produce twice as much propionate as acetate [26].
Twelve other food-grade dairy propionibacteria strains were also
tested (see Table S1 and Figure S1). Using these strains, twelve
fermented milks were obtained. Propionate concentrations ranged
from 36 to 67 mM and propionibacteria populations from 9.0 to
9.7 log10 cfu/mL, for the less and for the most efficient strain,
respectively.
The cytotoxic potential of supernatants prepared from milk or
milk ultrafiltrate, both fermented by P. freudenreichii ITG P9, was
investigated. HT-29 human colon cancer cells and HGT-1 human
gastric cancer cells were treated with these supernatants. Different
dilutions ranging from K to h were tested. Moreover, the
cytotoxicity of a mixture of 15 mM acetate and 30 mM
propionate was tested, at concentrations close to these K diluted
supernatants. As positive controls of apoptosis induction, the
chemotherapy drugs camptothecin (4 mM) and etoposide
(100 mM) were used for HGT-1 and HT-29 cells, respectively.
Three distinct methods of cell death monitoring were compared.
As shown in Figure S2, methylene blue, MTT and trypan blue
exclusion assays gave similar kinetics of death. Consequently,
methylene blue assay was used in this study to further assess cell
viability. The non-fermented dairy products (milk or milk
ultrafiltrate) had no effect, neither on HT-29, nor on HGT-1 cell
viability (Fig. 1 A,B). The supernatant of milk or milk ultrafiltrate
fermented by P. freudenreichii induced a similar cytotoxicity in a
time-dependent manner in HT-29 and HGT-1 cells, and close to
the cytotoxicity induced by drugs or by the acetate/propionate
mixture. Half-maximal killing of HGT-1 cells occurred after 24 h
and 26 h of treatment with the fermented milk and fermented milk
ultrafiltrate supernatants respectively, after 17 h of treatment with
camptothecin and after 24 h of treatment with SCFA mixture
(Fig. S3). In addition, the cytotoxicity of fermented dairy product
supernatants in HGT-1 cells was dose-dependent (Fig. 1C). For
each dilution tested, the drop in HGT-1 cell viability induced by
the fermented milk or the fermented milk ultrafiltrate was very
similar (Fig. 1C & Fig. S3). That’s why the next steps of the study
we performed only with the fermented milk ultrafiltrate superna-
tant. Taken together, these data indicate that propionibacteria
efficiently kill human colon and gastric cancer cells, at least in part
via the production of propionate and acetate (Fig. 1). Some other
fermented milks, fermented by different dairy propionibacteria
strains, showed similar cytotoxic effects on cancer cells (Table S2).
P. freudenreichii ITG P9 being known for its metabolic activity in vivo
[22], the corresponding fermented milk was further studied.
Fermented Milk-Induced Apoptosis of HGT-1 Cells
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e31892Figure 1. P. freudenreichii fermented milk kills human colorectal and gastric cancer cells. (A) Effect of P. freudenreichii fermented milk on
HT-29 human colorectal cancer cells. HT-29 cells were treated with a K dilution, in DMEMc, of supernatants obtained from fermented milk or
fermented milk ultrafiltrate (squares). As negative controls, cells were treated with K dilutions of unfermented milk or milk ultrafiltrate (diamonds). As
positive controls (triangles), cells were treated with DMEMc containing a mixture of acetate and propionate (C2/C3, 15/30 mM) or etoposide
(100 mM). (B) Effect of P. freudenreichii fermented milk on HGT-1 human gastric cancer cells. HGT1 cells were treated with a K dilution, in DMEMc, of
supernatants obtained from fermented milk or fermented milk ultrafiltrate (squares). As negative controls, cells were treated with K dilutions of
unfermented milk or milk ultrafiltrate (diamonds). As positive controls (triangles), cells were treated with DMEMc containing a mixture of acetate and
propionate (C2/C3, 15/30 mM) or camptothecin (4 mM). (C) Dose-dependence of fermented milk cytotoxic effect. HGT-1 cells were treated with
different dilutions of supernatant obtained from milk (empty symbols) or milk ultrafiltrate (plain symbols) both fermented by P. freudenreichii. Cell
viability was determined by the methylene blue assay after different periods of treatment. The percentage of viability was calculated using the
following formula: 1006(optical density values of treated cells/optical density values of non-treated cells). Results are mean values of three
experiments.
doi:10.1371/journal.pone.0031892.g001
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apoptosis in human gastric cancer cells
Nucleus morphology of HGT-1 cells incubated in the presence
of P. freudenreichii fermented milk ultrafiltrate was analyzed by
fluorescence microscopy after Hoechst 33342 staining (Fig. 2A).
The nuclear fluorescence of untreated cells (control) remained
unchanged during the time course of the experiment with blue
normal nuclei (time 0 h, Fig. 2Aa). During treatment, HGT-1
cells displayed the condensed chromatin and fragmented nuclei
characteristics of apoptotic nuclei (Fig. 2Ab, c), followed by the
appearance of apoptotic bodies at 72 h (Fig. 2Ad). Inter-
nucleosomal DNA fragmentation resulting in DNA laddering, a
typical mark of apoptosis [27], was also monitored during
fermented milk ultrafiltrate treatment. DNA fragmentation was
observed from 24 h of treatment with fermented milk ultrafiltrate
(Fig. 2B), and to a lesser extent with camptothecin (Fig. S3).
DNA content was also quantified by flow cytometry after
propidium iodide labeling to study the impact of fermented milk
ultrafiltrate on HGT-1 cell cycle distribution (Fig. 2C). Untreated
HGT-1 cells presented a cell cycle distribution (Fig. 2Ca) without
subG1 phase, which remained unchanged during the time course
of the experiment (data not shown). The percentage of cells in
subG1 phase, indicative of an apoptotic process, significantly
increased with time during fermented milk ultrafiltrate treatment
(Fig. 2Cb, Cc, Cd): at 24 h (39.2464.87%), at 48 h
(91.6360.28%) and at 72 h (94.7960.45%). At 48 h and 72 h
of treatment, all the cells were in the subG1 cell cycle phase,
indicating the complete death of HGT-1 cells. As a control,
camptothecin induced similar apoptotic hallmarks in HGT-1 cells
(Fig. S4).
To confirm apoptosis induction, phosphatdylserine transloca-
tion from the inner to the outer leaflet of the plasma membrane
was assessed by staining HGT-1 cells with a combination of
Annexin V-FITC (AV) and 7-AAD, followed by flow cytometry
fluorescence analysis (Fig. 3). Untreated cells (0 h) presented a
high proportion of live cells (AV
2/7AAD
2; 92%) and only 5% of
Figure 2. P. freudenreichii fermented milk ultrafiltrate induces typical nuclear marks of apoptosis in human gastric cancer cells. (A)
Fermented milk ultrafiltrate-induced nuclear condensation. Cells were cultured (0 h) or treated for 24, 48 or 72 h with a K dilution of P. freudenreichii
fermented milk ultrafiltrate (UF) supernatant. Cells were then stained with Hoechst 33342 prior to fluorescence microscopy. Arrows indicate
chromatin condensation (b), nuclear fragmentation (c) and formation of apoptotic bodies (d). (B) Fermented milk ultrafiltrate-induced DNA
fragmentation in HGT-1 cells. Genomic DNA was extracted and analyzed in 1% agarose gel. HGT-1 cells were treated as in (A). (C) Fermented milk
ultrafiltrate-induced changes in cell cycle phase distribution. DNA content of HGT-1 cells was analyzed by flow cytometry after propidium iodide
staining. Representative histograms corresponding to DNA content analysis of HGT-1 cells are shown. The percentage of the cell population with sub-
G1 DNA content, indicative of apoptosis, is indicated. Proportion of each cell subsets (sub-G1, G0/G1, S, G2/M), within the total cell population, is
shown for each time of treatment. Results are mean values of three independent experiments 6 sd. *P,0.05, **P,0.01, treated cells versus control
(0 h). The distribution of cell cycle phases of untreated cells (control) remained unchanged during the whole experiment.
doi:10.1371/journal.pone.0031892.g002
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determined in untreated cells did not change during the time
course of the experiment (data not shown). During the treatment
of HGT-1 cells with K diluted fermented milk ultrafiltrate in
DMEMc, the percentage of cells stained only by 7-AAD
(indicating necrosis) was very low (Fig. 3B). However, the
percentages of cells stained with Annexin V increased significantly
in a time-dependent manner and reached 80% at 72 h (Fig. 3B).
Hence, HGT-1 cells underwent apoptosis after treatment with P.
freudenreichii fermented milk ultrafiltrate, characterized by first AV
positive staining, indicating phosphatidylserine exposure, and then
both AV and 7-AAD positive staining, indicating a later loss of
membrane integrity. As a control, camptothecin induced similar
apoptotic hallmarks (Fig. S5).
As SCFA act directly on mitochondria, three important
mitochondrial parameters were also determined: the DYm inner
membrane potential, and the generation of ROS, using two
fluorescent probes, DiOC(6)3 (which is DYm-sensitive) and DHE
(which detects O2
2 level), and the localization of cytochrome c.
Untreated cells (0 h) exhibited a high fluorescence (high DYm)
and a low DHE fluorescence (low production of O2
2)( Fig. 4A,B).
After treatment with fermented milk ultrafiltrate, a time-
dependant decrease in incorporation of DiOC6(3) fluorescent
probe was observed, revealing a loss of DYm and hence
mitochondrial membrane depolarization (Fig. 4A). The percent-
ages of treated HGT-1 cells with decreased inner membrane
potential increased in a time-dependent manner to reach 96% of
cells at 72 h. FCCP treatment was used as a positive control of
mitochondrial membrane depolarization. This loss of DYm was
confirmed by the characteristic loss in red fluorescence following
JC-1 staining (Fig. 4B). Regarding ROS production in HGT-1
cells, fermented milk ultrafiltrate treatment induced accumulation
of O2
2-, significantly after 48 h and 72 h of treatment (Fig. 4C).
This ROS accumulation can be partially prevented if cells are pre-
treated by the ROS scavenger TEMPOL (Fig. S6). Cytochrome c
release from mitochondria to the cytoplasm is a key cellular event
of the apoptotic program. Immunoblotting examination of the
cytoplasm-enriched fractions for the presence of cytochrome c
confirmed a change in its subcellular localization (Fig. 4D).
Cytochrome c was detected in the cytoplasm-enriched fraction
from 24 h of treatment, indicating relocation of this protein
(Fig. 4D). This relocalization of cytochrome c in the cytoplasm
was confirmed by immunostaining, showing diffuse immunostain-
ing throughout the cell after treatment, while punctuated staining
before treatment (Fig. 4E).
P. freudenreichii fermented milk activates caspases
Toconfirmtheapoptoticmechanismsinducedbyfermentedmilk
ultrafiltrate in HGT-1 cells, processing of caspases 3, 8 and 9 was
analyzed bywesternblotting and correspondingenzymaticactivities
monitoring in HGT-1 cell extracts (Fig. 5). The non-fermented
milk ultrafiltrate did not induce caspase activation in HGT-1 cells:
only the proforms of caspase-3 and -9 were detected on western blot
(Fig. 5A) and no caspase activity was measured (Fig. 5B). The
fermentedmilk ultrafiltrate supernatant, aswell as the camptothecin
or the mixture of propionate and acetate in a [2: 1] molar ratio,
induced the cleavage of pro-caspase 3 and the generation of the
active forms of caspase-3, the subunits p17 and p12 (Fig. 5A). The
activation of caspase-3, which is an effector caspase, confirmed the
apoptosis induction. In addition, fermented milk ultrafiltrate
induced cleavage of procaspase-9, leading to the 35 and 37 kDa
processed forms. Caspase-8 was not detected in control untreated
HGT-1 cells. However, treatment with propionibacterial superna-
tants or C2/C3 mixture led to a clear detection of the 54 kDa
proform, followed by its cleavage after 48 h of treatment.
The quantification of the caspase-3, -8 and -9 enzymatic
activities confirmed caspase activation by both propionibacterial
metabolites and by camptothecin. Indeed, caspases-9 and -3 were
activated at the earliest stages of the treatment, while caspase-8
seemed activated later (Fig. 5B). Camptothecin and the SCFA
mixture activated all the three studied caspases. These data
confirmed the activation of the intrinsic pathway of apoptosis by
fermented milk ultrafiltrate treatment, with an early activation of
caspase-9 and then of caspase-3 and -8.
Figure 3. P. freudenreichii fermented milk ultrafiltrate induces phosphatidylserine exposure at the plasma membrane outer leaflet in
human gastric cancer cells. Flow cytometry kinetic analysis of cell death in HGT-1 cells treated with P. freudenreichii fermented milk ultrafiltrate.
(A) A representative experiment of Annexin V/7-AAD staining of HGT-1 cells at each time of treatment is shown, with proportions of Annexin V
positive cells (AV+; apoptotic cells). (B) Quantitative FACS analysis of Annexin V-FITC (AV) binding to HGT-1 cells was performed after counterstaining
with 7-aminoactinomycin-D (7AAD). Presented values correspond to the proportion of each cell subsets, within the total cell population, for each
treatment time. Results are mean values of three independent experiments 6 sd. *P,0.05, **P,0.01, treated cells versus control (0 h).
doi:10.1371/journal.pone.0031892.g003
Fermented Milk-Induced Apoptosis of HGT-1 Cells
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e31892Figure 4. P. freudenreichii fermented milk ultrafiltrate induces mitochondrial marks of apoptosis in human gastric cancer cells.
Kinetic analysis of mitochondrial events in HGT-1 cells treated with P. freudenreichii fermented milk ultrafiltrate (A) Flow cytometry kinetic analysis of
mitochondrial inner membrane (DYm) dissipation with DiOC(6)3 staining. An overlay view of a representative experiment is shown. The decoupling
FCCP (50 mM, 20 min) was used as positive control. Quantitative analyses of DYm loss in 3 independent experiments are shown. Values are
represented as a proportion of cells with low DYm, within the total cell population, for each treatment. Results are mean values of three independent
experiments 6 sd. *P,0.05, **P,0.01, treated versus control (0 h). (B) HGT-1 cells were stained with JC-1. The loss of mitochondrial membrane
potential is indicated by the progressive loss of red-JC-1-aggregate fluorescence and cytoplasmic diffusion of green monomer fluorescence(C) Flow
cytometry kinetic analysis of anion superoxide (O2
2) accumulation with DHE staining. An overlay of a representative experiment of ROS detection at
each time of treatment is shown. Cells were stained with dihydroethidium and analyzed by flow cytometry. The prooxidant menadione (Men.,
100 mM, 15 min) was used as positive control. Values are represented as a proportion of cells with increased ROS (increase of fluorescence intensity),
within the total cell population, for each treatment. Results are mean values of three independent experiments 6 sd. *P,0.05, **P,0.01, treated
versus control (0 h). (D) The cytochrome c relocation over the whole treatment period with P. freudenreichii fermented milk ultrafiltrate supernatant
K was assessed by western blot analysis. Following cell treatment, cytoplasm-enrich fractions were analyzed by western blotting and revealed using
an anti-cytochrome c antibody. Antibodies directed against Hsc-70 were used as a loading control. (E) Subcellular localization of cytochrome c. Cells
were immunostained with anti-cytochrome c antibody, following MitoTracker staining and prior to DNA staining using TO-PRO 3. The arrow indicates
diffusion of cytochrome c in the cytoplasm.
doi:10.1371/journal.pone.0031892.g004
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Campthotecin is a cytotoxic quinoline alkaloid which inhibits the
DNA enzyme topoisomerase I (topo I) and is widely used in the
chemotherapeutic treatment of GC. We have shown above that
propionibacterial metabolites induce apoptosis in HGT-1 cells via
the mitochondrial death pathway. We next studied apoptosis
induced by the combination of both camptothecin and fermented
milk ultrafiltrate in HGT-1 cells. Increased concentrations of
camptothecin (0, 0.25, 0.5, 1, 2 mM) in combination with increased
concentrations of fermented milk ultrafiltrate (0, h, F, J) were
tested on HGT-1 cell viability and both induced loss of HGT-1
viability, in a dose-dependent manner (Fig. 6). Moreover, the
addition of fermented milk ultrafiltrate enhanced significantly the
cytotoxicity of camptothecin in HGT-1 cells (Fig. 6). For example,
0.25 mM camptothecin and fermented milk ultrafiltrate diluted to
F led to a viability loss of 8.6% and 18.6%, respectively. The
combination of these two compounds led to a cell viability loss of
29.8% (Fig. 6), suggesting an added cytotoxicity effect when
camptothecin was combined with fermented milk ultrafiltrate in
HGT-1cells.Accordingly,thecombination index(CI),calculatedas
previously [28], has a value of 1, indicating an additive effect of
camptothecin and fermented milk ultrafiltrate treatments.
Discussion
A new fermented milk, containing P. freudenreichii as a sole
bacterium, was developed in order to further investigate the
probiotic potential of this dairy preparation of propionibacteria
(reviewed in [29]). In this study, we report that the aqueous phase
of this fermented milk kills human colon and gastric cancer cells
via metabolites, including propionate and acetate, released by this
bacterium. This notion is based on the observed cytotoxic effects
of P. freudenreichii fermented milk supernatants on cultured HT-29
and HGT-1 cancer cells. This effect was obtained with
ultracentrifugation supernatants, i.e. the fermented milk aqueous
phase, devoid of caseins and of bacteria, showing that the active
compounds are secreted, as previously described for propionibac-
teria [19]. For this reason, most of the experiments in this work
were performed with fermented milk ultrafiltrate (Fig. 1). We
demonstrated for the first time that P. freudenreichii fermented milk
supernatant induced apoptosis of HGT-1 cells in a time- and dose-
dependent manner with the appearance of classical morphological
and biochemical features of apoptosis (condensed and fragmented
chromation, DNA laddering and accumulation of cells in subG1
cell cycle phase).
We looked then if the cellular mechanisms involved in HGT-1
cell death pathway were similar to the mitochondrial death
pathway triggered in Caco-2 and HT-29 human colon cancer cells
by P. freudenreichii DMEMc culture supernatants [19,20]. The sub-
cellular and biochemical events observed in treated HGT-1 cells
with fermented milk ultrafiltrate were similar and included, at
least, mitochondrial DYm loss, ROS (O2
2) generation, caspases
processing and activation, cytochrome c relocation into the
cytoplasm (Fig. 3, 4, 5). Fermented milk supernatant induced
processing and activation of caspase-8, in addition to caspases -3
Figure 5. P. freudenreichii fermented milk ultrafiltrate activates caspases in human gastric cancer cells. Processing of effector caspase 3
and initiator caspases 8 and 9 was followed by western blotting and specific enzymatic activities monitoring in HGT-1 cells. (A) The proforms and
cleaved subunits of caspase 3, 8, and 9 were detected by western blotting in lysates of HGT-1 cells treated with P. freudenreichii fermented milk
ultrafiltrate supernatant K. Non-fermented milk ultrafiltrate (UF K, 48 h), a mixture of acetate and propionate (C2/C3, 15/30 mM, 48 h) and
camptothecin (4 mM, 48 h) were used as controls. Antibodies directed against Hsc-70 were used as a loading control. (B) Caspases specific activities of
lysates from cells treated as above were studied using indicated peptides and calculated as described in materials and methods. Results are mean
values of three experiments 6 sd. *P,0.05, **P,0.01, treated versus control (0 h).
doi:10.1371/journal.pone.0031892.g005
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detected in control untreated cells and in cells treated with
camptothecin or non-fermented milk ultrafiltrate, in line with the
lack of its mRNA (C. Le Jossic-Corcos, Faculty of Medicine, Brest,
France, personal communication). It should be noticed that an
apparent discrepancy exists between enzymatic results, suggesting
caspase-8 activity in camptothecin-treated cells, while no caspase-8
is detected in these cells by western blotting. This can be explained
by the lack of specificity of the Ac-IETD-AMC substrate, which
can be processed by other enzymes such as caspases -3 and -10 or
granzyme B, especially if the concentration of such enzymes is
elevated [30,31]. By contrast, P. freudenreichii fermented milk
ultrafiltrate and the mixture of SCFA both caused expression and
activation of caspase-8. The mechanisms involved here are not
elucidated; however, caspase-8 is known to be under-expressed in
some cancer cells as a result of DNA methylation [32,33]. Its
expression may be restored at the RNA and protein level by
demethylating agents such as decitabine [34] and HDAC
inhibitors [35], resulting in demethylation of the regulatory
sequence of caspase-8, an increase in caspase-8 promoter activity
and in re-expression of caspase-8 [32]. SCFA, such as propionate,
are HDAC inhibitors, leading to hyperacetylation of histones [36].
This favors transcription via a change in DNA conformation [37]
and could restore the caspase-8 expression. Other food-born
compounds were already shown to restore caspase-8 expression.
An injectable extract of Semen coicis (a relative of maize) extract
displaying anti-tumor activity enhances expression of caspase 8
and induces apoptosis in HepG2 cells [38]. Diallyl disulfide, found
in garlic, enhances expression of caspase-8, Fas and FasL in
leukemia K562 cells. Such a regulation may thus be involved in
the pro-apoptotic effects of dairy propionibacteria and of
fermented products containing them. Western blotting evidenced
restored expression and then late activation of caspase-8 in
propionibacterial metabolites-treated HGT-1 cells, which may
occur as a result of caspase-8 activation by an another caspase
such as caspase-9. Indeed, exit of cytochrome c, part of the
mitochondrial pathway, was shown to activate several caspases
including 2, 3, 6, 7, 8 and 10 [39]. Furthermore, caspase-9
activation was shown result in down-stream caspase-8 activation
[40]. Accordingly, caspase-9 was shown in vitro to activate caspase-
3 which in turns activates caspase-6, responsible for caspase-8
activation [41]. Altogether, our results confirm that propionibac-
terial metabolites present in P. freudenreichii fermented milk induce
several sub-cellular mechanisms favoring apoptosis. Such a
reactivation of caspase-8 expression could lead to a major
apoptotic response in HGT-1 cells treated with dead domain
receptors agonists (e.g. Trail or Fas).
To our knowledge, this is the first work reporting specific
induction of gastric cancer cell apoptosis by a fermented dairy
product. Fermented milks, including yogurt, were proposed to be
useful in the prevention of colon cancer. Epidemiological data on
the protective effects of milk and dairy products on colon cancer
rate gave conflicting results [42]. Milk and total dairy products
consumption is associated with a reduction in colorectal cancer
risk. But this is not true for all sorts of dairy products and effects
vary greatly. Fermented dairy products may constitute efficient
delivery vehicles to target protective molecules or microorganisms
to specific sites such as the digestive epithelium [43]. Bovine
lactoferrin, a constituent of milk, induces apoptosis of colon [44]
and gastric [45] cancer cells. Selected strains of microorganisms
present in fermented milks may also counteract colon carcinogen-
esis. Accordingly, yogurt and lactic acid bacteria exhibited anti-
cancer properties in animal models of colon carcinogenesis [46].
However, little work focused on fermented dairy products and
gastric cancer. Our work suggests that P. freudenreichii could play a
role in this context, as it would deliver both live propionibacteria
and pro-apoptotic metabolites to the gastric mucosa. In this
context, it should be noticed that P. freudenreichii adheres to
digestive epithelial cells and to mucus [47,48]. It was also shown to
inhibit adhesion of the causative agent of gastric cancer Helicobacter
pylori to digestive epithelial cells, as well as H. pylori-induced
damages [49]. These properties suggest a role of P. freudenreichii
fermented milk in the prophylaxis of gastric cancer.
Finally, our fermented milk potentialized the pro-apoptotic
action of the drug camptothecin on gastric cancer cells.
Accordingly, live cultures of probiotic lactobacilli were previously
shown to sensitize LS513 colorectal cancer cells to 5-fluorouracyl
[50]. However, in this case, the probiotics alone had no
proapoptotic effect. In this work, low doses of the drug
camptothecin used in gastric cancer chemotherapy were inefficient
Figure 6. P. freudenreichii fermented milk enhances camptothecin cytotoxicity in human gastric cancer cells. Viability of HGT-1 human
gastric cancer treated during 24 h was assessed by methylene blue assay. HGT-1 cells were treated with different concentrations of camptothecin (0
to 2 mM) together with different dilutions of P. freudenreichii fermented milk ultrafiltrate (UF) supernatant. The percentage of viability was calculated
by the following formula: 1006(optical density values of treated cells/optical density values of non-treated cells). Results are mean values of three
experiments 6 sd. *P,0.05, **P,0.01, treated cells versus controls (same camptothecin concentration without fermented milk ultrafiltrate
supernatant and same fermented milk ultrafiltrate supernatant dilution without camptothecin).
doi:10.1371/journal.pone.0031892.g006
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doses of P. freudenreichii fermented milk, they killed the same cells
efficiently (Fig. 6). Propionibacterial metabolites induce the
intrinsic apoptosis pathway by acting directly on mitochondria,
while camptothecin acts at the DNA level. This is consistent with
their cumulative potential in apoptosis induction when these pro-
apoptotic inducers are combined. Moreover, the fermented milk
contains SFCAs, known as HDAC inhibitors able to modulate
apoptosis and cell cycle in gastric cancer cells [13,51] as well as the
expression of cell cycle related and apoptotic proteins in other
cancer cells [52,53]. Probiotics were already used in clinical studies
to reduce the side effects of cancer chemotherapy [54]. P.
freudenreichii may, according to our results, be used in such clinical
studies. Its synergistic effect may help to lower the drug dose and
improve the comfort of patients.
In conclusion, a new milk, exclusively fermented by P.
freudenreichii, induced apoptosis in HGT-1 human gastric cancer
cells. In addition, this fermented milk enhanced the camptothecin
cytotoxicity activity, drug used in gastric cancer chemotherapy.
Such new probiotic fermented milk might be of interest as a
functional food to prevent gastric cancer and/or to potentialize
therapeutic treatments.
Materials and Methods
Chemicals
Camptothecin, etoposide, TEMPOL, acetate and propionate
sodium salts, and caspase substrates Ac-DEVD-AMC (N-Acetyl-Asp-
Glu-Val-Asp-7-amido-4-methylcoumarin), Ac-IETD-AMC (N-Acetyl-
Ile-Glu-Thr-Asp-7-Amido-4-methylcoumarin) and Ac-LEHD-AFC
(N-Acetyl-Leu-Glu-His-Asp-7-amido-4-trifluoromethylcoumarin) were
purchased from Sigma-Aldrich (Saint-Quentin Fallavier, France).
Camptothecin was dissolved in DMSO. The final concentration of
DMSO did not exceed 0.01%, a concentration that did not induce any
toxicity. RNAse A, PI (propidium iodide), Hoechst H33342,
MitoTrackerH Red CMXRos, TO-PRO-3, JC-1, 3,39-dihexyloxacar-
bocyanine iodide (DiOC6(3)) and dihydroethidium (DHE) were
obtained from Invitrogen (Cergy-Pontoise, France). Annexin V-FITC
(AV) kit and 7-aminoactinomycin-D (7-AAD) solution were provided
by BD Biosciences (Pont-de-Claix, France). Complete mini protease
inhibitor cocktail was obtained from Roche Applied Science (Meylan,
France). Mouse antibodies to caspase 8 (clone 12F5, Alexis
Biochemicals, Covalab, Villeurbanne, France), cytochrome c (clone
7H8.2C12, BD Biosciences) and Hsc-70 (clone B6, Santa Cruz
Biotechnology, Tebu-bio, Le Perray en Yvelines, France) and rabbit
antibodies to caspase 3 (clone H-277, Santa Cruz) and caspase 9 (Cell
Signalling Technology, Ozyme, Saint-Quentin-en-Yvelines, France)
were used for western blots. Polyvinylidene difluoride (PVDF)
membranes, horseradish peroxidase (HRP) conjugated secondary
antibodies and ECL plus kit were purchased from GE Healthcare
(Saclay, France). Sheep antibody to cytochrome c (Sigma-Aldrich) and
donkey anti-sheep IgG FITC-linked antibody (Sigma-Aldrich) were
used for confocal fluorescence microscopy.
Bacterial culture and supernatant preparation
The Propionibacterium freudenreichii ITG P9 strain (Institut
Technique du Gruye `re, Actilait, Rennes, France) used in this
study was provided by the CIRM-BIA (BIA138, see Table S1
formerly labeled TL133, Centre International de Ressources
Microbiennes - Bacte ´ries d’Inte ´re ˆt Alimentaire, INRA, Rennes,
France). It was routinely cultivated at 30uC without shaking in
milk ultrafiltrate (UF) supplemented with 100 mM of food-grade
sodium lactate (.97% L-lactate, galaflow SL 60, Socie ´te ´ Arnaud,
Paris, France) and 10 g/L of casein hydrolysate (Organotechnie,
La Courneuve, France), sterilized by 0.2 mm filtration (Nalgene,
Roskilde, Denmark). To prepare experimental fermented milk,
UHT milk (skimmed milk, UHT, Agrilait, Cesson-Se ´vigne ´,
France) or milk ultrafiltrate (obtained as previously described
[55]) was supplemented with 50 mM sodium lactate and 5 g/L
casein peptone, inoculated (1%) with P. freudenreichii and incubated
during 3 days at 30uC. After growth, bacterial supernatants were
prepared by centrifugation (12 0006 g,4 uC, 15 min) for
fermented milk ultrafiltrate or by ultra-centrifugation (100 0006
g,4 uC, 1 h) for fermented milk, neutralized at pH 7 and filter-
sterilized as above. The bacterial concentration was determined by
CFU counting on YEL agar before centrifugation and production
of propionate and acetate was quantified in supernatants by
HPLC as previously described [19].
Cell lines and culture conditions
The human gastric cancer cell line HGT-1 was a kind gift of
Dr Laboisse (INSERM, Nantes). The HT-29 human colon
adenocarcinoma cell line was obtained from ATCC (American
Type Culture Collection, Rockville, MD). Cell lines were was
cultured at 37uC under a humidified atmosphere of 5% CO2 in
DMEM medium (GlutaMAX
TM, high glucose, Gibco-Invitro-
gen) supplemented with 10% heat inactivated-fetal calf serum
(PAN, Dominique Dutscher, Brumath, France) and antibiotics
[56].
Cell treatments
HGT-1 cells were plated with DMEMc (DMEM with
inactivated-fetal calf serum) without antibiotics during at least
one night for attachment. When cells reached 75% confluence, the
medium was replaced with fresh medium (control) or with
treatment media. To treat cells, non-fermented milk ultrafiltrate
or milk, and supernatants of milk ultrafiltrate or milk both
fermented by P. freudenreichii were diluted, from two (K) to sixteen
times (h), in DMEMc. To study the impact of propionibacterial
SCFA, DMEMc supplemented with 15 mM acetate and 30 mM
propionate, as previously quantified in the P. freudenreichii DMEMc
supernatants [19], was used. As a positive control of apoptosis
induction, cells were also treated with 4 mM camptothecin (HGT-
1) or 100 mM etoposide (HT-29), an anticancer drug known to
induce apoptosis [57]. Treatments were performed during 24 h,
48 h and 72 h.
Cell viability monitoring
Viability of HGT-1 cells was assessed by methylene blue assay
as previously described [58]. The percentage of viability was
calculated by the following formula: 1006(optical density values of
treated cells/optical density values of non-treated cells).
DNA labeling and fluorescence microscopy
HGT-1 cells were trypsinized, harvested and resuspended in
phosphate-buffered saline (PBS) with 1.6 mM of the DNA
intercalating Hoechst H33342 compound. After a 30-min
incubation at 37uC in the dark, cells were observed under an
Optiphot fluorescence microscope (Nikon, Champigny sur Marne,
France). Numerical pictures were obtained with a D300 camera
(Nikon, Champigny sur Marne, France).
Confocal microscopy
For potential membrane mitochondria observation, cells were
cultured on compartmented glass coverslips before treatment.
Following treatment, cells were stained with the JC-1 probe
(10 mg/mL, 30 min, 37uC) as described previously [59].
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stained with 100 nM Mitotracker in DMEM without fetal calf
serum (30 min, 37uC). After washes, HGT-1 cells were fixed
(30 min, PBS, 4% paraformaldehyde) and then blocked and
permeabilized with blocking solution (PBS, 2% Bovine Serum
Albumin, 0.2% Triton X-100) during 1 h. Then, after washes,
cells were incubated with sheep antibody raised against cyto-
chrome c in blocking solution (dilution 1:650, 2 h30). After
washes, coverslips were incubated with anti-sheep IgG FITC-
linked secondary antibody (dilution 1:40) and with TO-PRO-3
(1 mM) diluted in blocking solution in the dark during 1 h.
After washing, cells were examined with a Nikon C1Si Laser
Scanning Confocal Imaging System on inverted microscope
TE2000-E (Nikon, Champigny-sur-Marne, France), equipped
with an argon ion laser and two helium/neon lasers emitting
respectively at 488, 543 and 633 nm.
DNA fragmentation
HGT-1 cells were trypsinized, harvested and resuspended in
lysis buffer (10 mM Tris-HCl pH 8, 10 mM EDTA, 1% Triton
X100) containing 200 mg/ml of proteinase K. After incubation at
56uC for 2 h, RNA was digested by RNAse A (100 mg/mL) during
1 h at 37uC. Then, DNA was purified by phenol/chloroform
extraction and precipitated by addition of 0.3 M sodium acetate
and 2 volumes of cold ethanol as previously described [57]. The
precipitates were centrifuged (12 0006 g, 20 min, 4uC), and the
pellets were air dried and resuspended in 10 mM Tris HCl pH 8
containing 1 mM EDTA. The DNA was quantified using a
NanoDrop apparatus (Thermo scientific, Labtech, Palaiseau,
France) according to the manufacturer’s instructions. DNA
fragmentation was analyzed by 1% agarose gel electrophoresis of
DNA (3 mg) and staining with gelRed.
Cell cycle analysis
HGT-1 cells were harvested by trypsinization, washed and
incubated overnight with cold 70% ethanol in PBS prior to
staining with a 40 mg/mL propidium iodide solution in PBS with
50 mg/mL RNase A (30 min, 37uC, in dark). 10 000 cells were
analyzed for fluorescence emission (FL-3) by using a FACS flow
cytometer FC500 (BD Biosciences) and the CXP software (BD
Biosciences). This software was used to generate DNA content
frequency histograms and quantify the amount of cells in the
individual cell cycle phases including subG0/G1 population.
Three independent experiments were carried out.
Cell viability and apoptosis analysis by Annexin V/7-AAD
staining
HGT-1 cells were trypsinized and harvested as described above.
After washes in PBS, cells were stained with Annexin V-FITC and
7-AAD according to the manufacturer’s instructions. Cells were
then analyzed by flow cytometry. Cell analysis and data processing
were carried out on 10 000 cells using the same device and
software as above. Three independent experiments were per-
formed.
Reactive oxygen species detection
Production of ROS was assessed by flow cytometry using
dihydroethidium (DHE) probe to detect superoxide anion (O2
2)a s
previously described [60]. HGT-1 cells were harvested as
described above, washed in PBS, and labeled with 5 mM DHE
(15 min, 37uC, in the dark). Fluorescence emission (FL-1) of
oxidized DHE was analyzed by flow cytometry for 10 000 cells.
Menadione (100 mM, 20 min) was used as a positive control.
Superposition of control and menadione histograms allowed
defining a gate for calculating the percentage of cells accumulating
O2
2. Experiments were conducted in triplicate.
Analysis of mitochondrial membrane potential (DYm)
Disruption of DYm was monitored by flow cytometry using
3,39dihexyloxacarbocyanine iodide (DiOC6(3)) probe. HGT-1
cells were harvested as described above and washed with PBS,
incubated with 50 nM DiOC6(3) (20 min, 37uC, in the dark). The
decoupling agent carbonyl cyanide p-trifluoromethoxy-phenylhy-
drazone (FCCP; 50 mM, 20 min) served as a positive control for
DYm loss. Fluorescence emission (FL-1) was analyzed by flow
cytometry or 10 000 cells. Superposition of control and FCCP
histograms allowed to define a gate for calculating the percentage
of cells with a decreased DiOC6(3) incorporation. Three
independent experiments were carried out.
Western blot analysis
HGT-1 cells were harvested as described above and cell pellets
were stored at 280uC until extraction. Pellets were resuspended in
lysis buffer (1% SDS, 10 mM DTT, protease inhibitor cocktail,
10 mM Tris-HCL pH 7.4) and sonicated. Cellular fragments were
eliminated by centrifugation (11,0006g, 3 min, 4uC). To obtain a
cytosol-enriched fraction, proteins were extracted as previously
described [61]. Protein concentration of the total and cytosol-rich
fractions was determined by the Bradford method. Proteins (50 mg)
were separated on a polyacrylamide sodium dodecylsulfate (SDS)-
containing gel and transferred to a PVDF membrane. After
blocking nonspecific binding sites for 1 h at room temperature by
5% nonfat milk in TPBS (PBS with 0.1% Tween 20), membranes
were incubated overnight at 4uC with specific antibodies. Then,
membranes were washed twice with TPBS, incubated for 1 h at
room temperature with horseradish peroxidase-conjugated goat
anti-mouse or anti-rabbit Abs, washed twice with TPBS before
revelation using an enhanced chemiluminescence detection kit
(GE healthcare, Ve ´lizy, France). Protein bands were visualized
with a Syngene G:Box (Ozyme, Saint-Quentin-en-Yvelines,
France).
Measurement of caspase activities
Caspase-3 is the major effector (or executioner) caspase of
apoptosis. Caspase-8 is an initiator caspase involved in the
extrinsic (via death receptors) pathway of apoptosis. Caspase-9 is
an initiator caspase involved in the intrinsic (via mitochondria)
pathway of apoptosis [16]. Activity of the caspases -3, -8 and -9
was assessed as previously described [62]. Briefly, cell lysates
were obtained and tested for their caspase activities using
specific substrates. Caspase-3 activity was measured using the
substrate Ac-DEVD-AMC, caspase-8 activity with Ac-IETD-
AMC and caspase-9 activity with Ac-LEHD-AFC. Caspase
activities were measured by monitoring fluorescence continu-
ously in a dual luminescence fluorometer (Spectra max Gemini
XS, Molecular Devices, Sunnyvale, CA, USA) using specific
excitation and emission wavelengths for each peptide. Enzyme
activity was determined as initial velocities and expressed as
relative intensity (arbitrary unit)/min/mg protein. The experi-
ments were performed in triplicates for each experimental
condition.
Statistical analysis
Results are expressed as the mean 6 standard deviation (sd).
Significance was determined by Student’s t test for paired samples.
The significance is shown as follows: *P,0.05; **P,0.01.
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Figure S1 Propionibacterial population and SCFAs
production of 12 dairy propionibacteria strains in
fermented milk. Twelve dairy propionibacteria strains (supple-
mental Table S1) were cultivated during 3 days at 30uC. (A)
Populations of dairy propionibacteria in fermented milks were
determined by enumeration. (B) Production of short-chain fatty
acids by dairy propionibacteria in fermented milks was determined
by HPLC. (A,B) The results are means of at least two independent
experiments.
(TIF)
Figure S2 Kinetics of cell death induced by propioni-
bacterial metabolite (A) or by camptothecin (B) is
detected by 3 methods. HGT-1 were treated as in Figure 1.
Viability was monitored by methylene blue, MTT and trypan blue
exclusion assays. Consistent results are obtained.
(TIF)
Figure S3 Time course leading to 50% of HGT-1 cell
death (T1/2) by fermented milk ultrafiltrate or ferment-
ed milk. Time course leading to 50% of HGT-1 cell death (T1/2)
was determined with the methylene blue assay described in
Figure 1C. Results are mean values of three experiments 6 sd.
(TIF)
Figure S4 Camptothecin induces typical nuclear marks
of apoptosis in human gastric cancer cells (positive
control for Figure 2). (A) Camptothecin-induced nuclear
condensation. Cells were cultured (Co.) or treated for 24, 48 or
72 h with 4 mM camptothecin. Cells were then stained with
Hoechst 33342 prior to fluorescence microscopy. Arrows indicate
chromatin condensation (b), nuclear fragmentation (c) and
formation of apoptotic bodies (d). (B) Camptothecin-induced
DNA fragmentation in HGT-1 cells. Genomic DNA was extracted
and analyzed in 1% agarose gel. HGT-1 cells were treated as in
(A). (C) Camptothecin-induced changes in cell cycle phases. DNA
content of HGT-1 cells was analyzed by flow cytometry after
propidium iodide staining. Representative histograms correspond-
ing to DNA content analysis of HGT-1 cells are shown. The
percentage of the cell population with sub-G1 DNA content,
indicative of apoptosis, is indicated. Proportion of each cell subsets
(sub-G1, G0/G1, S, G2/M), within the total cell population, is
shown for each time of treatment. Results are mean values of three
independent experiments 6 sd. *P,0.05, **P,0.01, treated cells
versus control (0 h). The distribution of cell cycle phases of
untreated cells (control) remained unchanged during the whole
experiment.
(TIF)
Figure S5 Camptothecin induces phosphatidylserine
exposure at the plasma membrane outer leaflet in
human gastric cancer cells (positive control for
Figure 3). Flow cytometry kinetic analysis of cell death in
HGT-1 cells treated with 4 mM camptothecin. (A) A representative
experiment of Annexin V/7-AAD staining of HGT-1 cells at each
time of treatment is shown, with proportions of Annexin V positive
cells (AV+; apoptotic cells). (B) Quantitative FACS analysis of
Annexin V-FITC (AV) binding to HGT-1 cells was performed
after counterstaining with 7-aminoactinomycin-D (7AAD). Pre-
sented values correspond to the proportion of each cell subsets,
within the total cell population, for each treatment time. Results
are mean values of three independent experiments 6 sd. *P,0.05,
**P,0.01, treated cells versus control (0 h).
(TIF)
Figure S6 The ROS scavenger TEMPOL lowers propio-
nibacterial metabolites-induced accumulation of anion
superoxide (O2
2). HGT-1 cells were treated as in Figure 4C in
the presence or absence of 5 mM TEMPOL. Flow cytometry
analysis of anion superoxide (O2
2) accumulation with DHE
staining. (A) Overlays of a representative experiment of ROS
detection. Cells were stained with dihydroethidium and analyzed
by flow cytometry. The prooxidant menadione (Men., 100 mM,
15 min) was used as positive control. (B) Values are represented as
a proportion of cells with increased ROS (increase of fluorescence
intensity), within the total cell population, for each treatment.
Results are mean values of three independent experiments 6 sd.
*P,0.05, **P,0.01, no TEMPOL versus TEMPOL.
(TIF)
Table S1 Dairy propionibacteria strains and their
origin.
(DOC)
Table S2 Dairy propionibacteria fermented milks in-
duce apoptosis in human colorectal cells HT-29.
(DOC)
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